Clinical trial
The Role of ctDNA and PBMC as Biomarkers in Diagnostic, Efficacy Monitoring and Prognostic Evaluation of Biliary Tract Cancer
NCT02809898 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Role of ctDNA and PBMC as Biomarkers in Diagnostic, Efficacy Monitoring and Prognostic Evaluation of Biliary Tract Cancer
- Lead sponsor
- RenJi Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- July 31, 2016
- Completion date
- December 31, 2020
- Enrollment
- 30 (estimated)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.